Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic markers in pheochromocytoma

M R Clarke1, R J Weyant, C G Watson

  • 1Department of Pathology, University of Pittsburgh School of Medicine, PA, USA.

Human Pathology
|May 22, 1998
PubMed
Summary

Malignant pheochromocytomas are difficult to distinguish. The MIB-1 labeling index, male gender, and extra-adrenal location are associated with malignancy, with MIB-1 being an independent predictor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Relationships of Dentition, Use of Dental Prothesis and Oral Health Problems with Frailty, Disability and Diet Quality: Results from Population-Based Studies of Older Adults from the UK and USA.

The journal of nutrition, health & aging·2023
Same author

Plaque Microbiome in Caries-Active and Caries-Free Teeth by Dentition.

JDR clinical and translational research·2022
Same author

Genome-wide Scan of Dental Fear and Anxiety Nominates Novel Genes.

Journal of dental research·2022
Same author

Opposition to Early Dental Visit by Dentists: A Qualitative Study on Mothers' Social Networks.

JDR clinical and translational research·2021
Same author

<i>The Lancet</i> Oral Health Series: Implications for Oral and Dental Research.

Journal of dental research·2019
Same author

Pilot GWAS of caries in African-Americans shows genetic heterogeneity.

BMC oral health·2019

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Distinguishing benign from malignant pheochromocytomas is challenging using standard clinical and histopathological features.
  • There is a need for additional prognostic markers in the pathological assessment of pheochromocytomas.

Purpose of the Study:

  • To investigate immunohistochemical markers for predicting malignancy in pheochromocytomas.
  • To identify reliable prognostic indicators for pheochromocytoma pathology.

Main Methods:

  • Immunohistochemical analysis of MIB-1, Bcl-2, cathepsin B, cathepsin D, bFGF, c-met, and type IV collagenase in 33 pheochromocytoma cases.
  • Correlation of marker expression with clinical and histopathological features and long-term follow-up data to assess malignancy.

Main Results:

  • MIB-1 labeling index (P = .0009), male gender (P = .008), extra-adrenal location (P = .03), increased tumor weight (P = .05), and younger age (P = .05) were associated with malignancy.
  • MIB-1 labeling index >3% showed 100% specificity and 50% sensitivity for predicting malignancy.
  • Neurofibromatosis (NF) cases were not malignant (P = .04).

Conclusions:

  • MIB-1 labeling index is a significant independent predictor of malignancy in pheochromocytomas.
  • Clinical factors like male gender and extra-adrenal location, alongside MIB-1 expression, aid in assessing pheochromocytoma malignancy risk.
  • Further research into prognostic markers is warranted for improved patient management.

Related Experiment Videos